Cutaneous T-cell lymphomas may require an exception to the ABHH consensus regarding empiric vancomycin use in febrile neutropenia
- PMID: 40382880
- PMCID: PMC12145817
- DOI: 10.1016/j.htct.2025.103844
Cutaneous T-cell lymphomas may require an exception to the ABHH consensus regarding empiric vancomycin use in febrile neutropenia
Conflict of interest statement
Conflicts of interest Yung Gonzaga received honoraria and speakers' fees from Takeda. Jose A. Sanches received honoraria and speakers' fees from Takeda.
References
-
- Nucci M., Arrais-Rodrigues C., Bergamasco M.D., Garnica M., Gloria A.B.F., Guarana M., et al. Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH. Hematol Transfus Cell Ther. 2024;46(Suppl 6):S346–S361. doi: 10.1016/j.htct.2024.11.119. - DOI - PMC - PubMed
-
- Martinez-Nadal G., Puerta-Alcalde P., Gudiol C., Cardozo C., Albasanz-Puig A., Marco F., et al. Inappropriate empirical antibiotic treatment in high-risk neutropenic patients with bacteremia in the era of multidrug resistance. Clin Infect Dis. 2020;70(6):1068–1074. doi: 10.1093/cid/ciz319. - DOI - PubMed
-
- Chumbita M., Puerta-Alcalde P., Gudiol C., Garcia-Pouton N., Laporte-Amargós J., Ladino A., et al. Impact of empirical antibiotic regimens on mortality in neutropenic patients with bloodstream infection presenting with septic shock. Antimicrob Agents Chemother. 2022;66(2) doi: 10.1128/AAC.01744-21. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
